Inactive Instrument

Luckwel Pharmaceuticals Inc.

LWEL

US54959L1017

Luckycom Pharmaceuticals Inc. has Changed its Name to Luckwel Pharmaceuticals Inc

April 13, 2018 at 12:00 am

On April 13, 2018, Luckycom Pharmaceuticals Inc. changed its name to Luckwel Pharmaceuticals Inc.

Latest news about Luckwel Pharmaceuticals Inc.

Luckwel Pharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended June 30, 2020	21-09-07	CI
Luckwel Pharmaceuticals Inc. Reports Earnings Results for the Full Year Ended March 31, 2020	21-06-10	CI
Luckwel Pharmaceuticals Inc. announced that it expects to receive $0.075 million in funding from Bounty Company Limited	21-05-13	CI
Luckwel Pharmaceuticals Inc. announced that it expects to receive $0.12 million in funding	21-04-19	CI
Luckwel Pharmaceuticals Inc. Announces Address Changes	21-01-04	CI
Luckwel Pharmaceuticals Inc. Reports Earnings Results for the Third Quarter Ended December 31, 2019	20-02-13	CI
Luckwel Pharmaceuticals Inc. Reports Earnings Results for the Second Quarter Ended September 30, 2019	19-11-14	CI
Luckwel Pharmaceuticals Inc. Reports Earnings Results for the Full Year Ended March 31, 2019	19-07-02	CI
Luckwel Pharmaceuticals Inc. Reports Earnings Results for the Third Quarter Ended December 31, 2018	19-02-14	CI
Luckycom Pharmaceuticals Inc. has Changed its Name to Luckwel Pharmaceuticals Inc	18-04-13	CI
Luckwel Pharmaceuticals Inc. has Changed its Ticker to LWEL from LCOM	18-04-13	CI
Luckycom, Inc. will Change its Name to Luckycom Pharmaceuticals Inc	17-04-18	CI
Luckycom Pharmaceuticals Inc. will Change its Ticker to LCOM from LKYM	17-04-18	CI
Luckycom Inc Auditor Raises 'Going Concern' Doubt	16-05-01	CI
Luckycom Inc Announces Fiscal Year Change from February 28 or 29 to March 31	16-02-11	CI
Luckycom Inc Auditor Raises 'Going Concern' Doubt	15-05-31	CI
Luckycom Inc Auditor Raises 'Going Concern' Doubt	14-05-14	CI

Chart Luckwel Pharmaceuticals Inc.

Duration

Period

More charts

Luckwel Pharmaceuticals Inc. creates medicine to cure diseases. The Company is focused on autoimmune disease, human immunodeficiency virus (HIV) / acquired immune deficiency syndrome (AIDS) and infectious diseases. The Companyâs pipelines include LWEL-2120 for the treatment of rheumatoid arthritis (RA), LWEL-2119 for the treatment of HIV and LWEL-2103 for the treatment of COVID-19.

Sector

Investment Holding Companies

More about the company

Sector Shell Companies

	1st Jan change	Capi.
TRUMP MEDIA & TECHNOLOGY GROUP CORP.	+205.49%	7.06B
CHURCHILL CAPITAL CORP VII	+2.10%	982M
SCREAMING EAGLE ACQUISITION CORP.	-3.96%	954M
APPLE ISPORTS GROUP, INC.	+41.91%	872M
PERELLA WEINBERG PARTNERS	+22.57%	800M
ARES ACQUISITION CORPORATION II	+1.77%	664M
E7 GROUP	+7.72%	659M
DA ZHONG TRADING GROUP HOLDING COMPANY	-.--%	600M
ADMIRAL ACQUISITION LIMITED	+3.61%	503M

Shell Companies